Mad3 inhibitors as a chemical class would encompass a range of compounds that can indirectly affect the function of Mad3 by targeting various aspects of the SAC or related mitotic processes. Since Mad3 is not an enzyme, these inhibitors would not act by blocking a catalytic activity but would instead work by disrupting the protein-protein interactions or the proper assembly and function of the mitotic spindle, which are crucial for Mad3's role in the SAC.
The inhibitors would typically function by altering the dynamic equilibrium of microtubules (as with microtubule-stabilizing or depolymerizing agents), inhibiting key kinases involved in the SAC (such as Aurora kinases, Plk1, or Mps1), or modulating other cellular kinases that indirectly impact mitotic progression and SAC function. Through these mechanisms, the inhibitors can prevent proper checkpoint signaling, which is essential for Mad3's role in delaying the onset of anaphase until all chromosomes are correctly attached to the spindle. These compounds often target proteins that are upstream or within the same pathway as Mad3, such as kinases essential for the initiation and maintenance of the checkpoint. By inhibiting these kinases, the compounds can interfere with the SAC, thus indirectly impacting Mad3's function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Monastrol | 254753-54-3 | sc-202710 sc-202710A | 1 mg 5 mg | $120.00 $233.00 | 10 | |
A kinesin Eg5 inhibitor that disrupts mitotic spindle formation, thereby potentially affecting Mad3's role in SAC. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
A microtubule-depolymerizing agent that activates the SAC, which could indirectly affect Mad3 by altering checkpoint signaling. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
A microtubule-stabilizing agent that can trigger the SAC; could affect Mad3 function due to changes in microtubule dynamics. | ||||||
BI6727 | 755038-65-4 | sc-364432 sc-364432A sc-364432B sc-364432C sc-364432D | 5 mg 50 mg 100 mg 500 mg 1 g | $150.00 $1050.00 $1665.00 $3329.00 $4382.00 | 1 | |
A Plk1 inhibitor that can impact mitotic entry and spindle assembly, potentially influencing Mad3 activity. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
An Aurora kinase inhibitor that affects chromosome alignment and the SAC, could alter Mad3's regulatory functions. | ||||||
AZ 3146 | 1124329-14-1 | sc-361114 sc-361114A | 10 mg 50 mg | $218.00 $905.00 | 7 | |
An Mps1 kinase inhibitor that can affect SAC signaling and thus could modulate Mad3's function. | ||||||
Purvalanol B | 212844-54-7 | sc-361300 sc-361300A | 10 mg 50 mg | $199.00 $846.00 | ||
A cyclin-dependent kinase inhibitor (CDK) that can arrest cells in G2/M, potentially affecting Mad3 function. | ||||||
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
An Aurora A kinase inhibitor, impacting spindle assembly and checkpoint function, which could affect Mad3. | ||||||
S-Trityl-L-cysteine | 2799-07-7 | sc-202799 sc-202799A | 1 g 5 g | $32.00 $66.00 | 6 | |
A kinesin Eg5 inhibitor, similar to monastrol, potentially influencing Mad3's role in the SAC. | ||||||
MLN 8054 | 869363-13-3 | sc-484828 | 5 mg | $398.00 | ||
An Aurora kinases A and B inhibitor, which can modulate Mad3 activity by affecting the checkpoint. | ||||||